Table 1 Comparison of standard IF-F and IF-FFPE after Try-30/MW-TEB pretreatment
IgG | IgA | IgM | C3 | TEM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Case | Diagnosis | IF-FFPE | IF-F | IF-FFPE | IF-F | IF-FFPE | IF-F | IF-FFPE | IF-F | Dens bodies |
1 | ICGN | +++ | +++a | + | + | + | + | +++ | ++ | +++b/sepi |
2 | ICGN | +++ | +++ | + | + | + | −/+ | ++ | +++ | +++/sepi |
3 | ICGN | ++ | + | −/+ | + | −/+ | + | ++ | ++ | ++/sepi |
4 | ICGN | + | + | – | – | + | + | + | + | +/pme and sendo |
5 | ICGN | −/+ | −/+ | + | −/+ | ++ | ++ | −/+ | + | +/pme and sendo |
6 | ICGN | −/+ | −/+ | – | −/+ | −/+ | + | −/+ | + | +/pme and sendo |
7 | ICGN | −/+ | – | +++ | +++ | + | + | + | + | +/me |
8 | ICGN | + | + | +++ | +++ | – | −/+ | + | + | +/me |
9 | Non-ICGN | −/+ | – | −/+ | −/+ | + | −/+ | – | −/+ | – |
10 | Non-ICGN | −/+ | – | – | −/+ | + | −/+ | −/+ | −/+ | – |
11 | Non-ICGN | – | – | – | – | – | – | – | – | – |
12 | Amyloidosis | – | – | −/+ | – | −/+ | – | −/+ | – | – |